Contact
Let's talk formulation.
Every project starts with a technical conversation. Tell us about your active ingredient, your target format and your formulation goals. Our R&D team will follow up to scope next steps.
Process
What happens after you write
- 01
Technical brief
You tell us the active, the target format and the constraints that matter — licensing, co-development or transfer.
- 02
Screening conversation
A short call with the scientific team to test fit: particle strategy, format and whether the NLC platform is the right path.
- 03
Scoped next steps
If there is a fit, we outline the pathway — ingredient review, prototype work or IP documentation under NDA.
Direct contact
Vanessa Häusler
Write or call Vanessa Häusler for a direct conversation. The inquiry form remains the working channel for formulation and licensing briefs.
- Phone
- +41 79 293 00 96
- Turgor Therapeutics GmbH
- Baarerstrasse 43, 6300 Zug, Switzerland
